Science Explorer Back to mapMap
Discussion
Topic · Neurology

Myasthenia Gravis and Thymoma

Myasthenia Gravis and Thymoma is a research topic within Neurology. Science Explorer counts 26k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the research related to myasthenia gravis, including its subgroups, clinical correlates, treatment strategies, and the role of autoantibodies. Additionally, it explores the classification and prognosis of thymic tumors, the efficacy of thymectomy, and the epidemiology of these conditions.

  • Myasthenia Gravis
  • Thymic Tumors
  • Autoantibodies
  • MuSK Antibodies
  • Thymectomy
  • Epidemiology
  • Immunotherapy
  • Neuromuscular Junction
  • Classification System
  • Prognosis
Research works
26k
fractional, since 1950
In the world top 10%
2.6k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+16%
the tick is no change
Largest producer
United States
31% of the 10 largest, 2022-now
Myasthenia Gravis and Thymoma

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Myasthenia Gravis and Thymoma research?

By volume, the United States and China publish the most (1.1k and 696 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.1k works
  2. 2 China 696 works
  3. 3 Japan 407 works
  4. 4 India 268 works
  5. 5 Italy 226 works
  6. 6 United Kingdom 193 works
  7. 7 Germany 181 works
  8. 8 France 132 works
  9. 9 Türkiye 126 works
  10. 10 Spain 113 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.3%China: 20.4%Japan: 11.9%India: 7.8%6 others listed: 28.5%31%largest
United States1,068 · 31.3%China696 · 20.4%Japan407 · 11.9%India268 · 7.8%6 others listed971 · 28.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Myasthenia Gravis and Thymoma research?

By volume in 2022-now, Harvard University publishes the most Myasthenia Gravis and Thymoma research, followed by Mayo Clinic and All India Institute of Medical Sciences.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 41 works
  2. 2 Mayo ClinicUnited States 35 works
  3. 3 All India Institute of Medical SciencesIndia 33 works
  4. 4 Sun Yat-sen UniversityChina 31 works
  5. 5 Cleveland ClinicUnited States 30 works
  6. 6 Shanghai Jiao Tong UniversityChina 27 works
  7. 7 Fudan UniversityChina 27 works
  8. 8 Capital Medical UniversityChina 23 works
  9. 9 Sichuan UniversityChina 22 works
  10. 10 University of TorontoCanada 21 works

Who are the leading researchers in Myasthenia Gravis and Thymoma?

The most-cited researchers publishing on Myasthenia Gravis and Thymoma include Cyrus Cooper and Giuseppe Remuzzi.

  1. 1 Cyrus Cooper United Kingdom 342k citations
  2. 2 Giuseppe Remuzzi Italy 328k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Myasthenia Gravis and Thymoma?

The most cited paper in Myasthenia Gravis and Thymoma is "Follow-up study of thymomas with special reference to their clinical stages" (Akira Masaoka, Yasumasa Monden, Kazuya Nakahara et al., 1981), with 1,725 citations. Next come "Myasthenia gravis" (1,657) and "Localized mediastinal lymph-node hyperplasia resembling thymoma" (1,635).

Most cited papers
#PaperReleasedCitations
1 Follow-up study of thymomas with special reference to their clinical stages Akira Masaoka, Yasumasa Monden, Kazuya Nakahara et al. · Cancer Dec 1981 1,725
2 Myasthenia gravis Alfred Jaretzki, Richard J. Barohn, Raina M. Ernstoff et al. · Neurology 12 Jul 2000 1,657
3 Localized mediastinal lymph-node hyperplasia resembling thymoma Benjamin Castleman, Lalla Iverson, V. Pardo Menendez · Cancer Open access Jul 1956 1,635
4 Paresis Acquired in the Intensive Care Unit A Prospective Multicenter Study Bernard De Jonghe · JAMA 11 Dec 2002 1,533
5 Myasthenia gravis: subgroup classification and therapeutic strategies Nils Erik Gilhus, Jan J.G.M. Verschuuren · The Lancet Neurology 13 Sep 2015 1,262
All 98 most cited papers, with filters and sorting

Where is Myasthenia Gravis and Thymoma research done?

The largest centres of Myasthenia Gravis and Thymoma research in 2022-now are Beijing (China), Tokyo (Japan), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Cleveland.

Largest cities, 2022-now

  1. 1 BeijingChina 88 works
  2. 2 TokyoJapan 85 works
  3. 3 ShanghaiChina 73 works
  4. 4 GuangzhouChina 60 works
  5. 5 ParisFrance 51 works
  6. 6 LondonUnited Kingdom 51 works
  7. 7 New YorkUnited States 50 works
  8. 8 SeoulSouth Korea 44 works
  9. 9 BostonUnited States 42 works
  10. 10 IstanbulTürkiye 42 works

Where it is the local speciality

  1. ClevelandUS · 39.1 works5.9×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Myasthenia Gravis and Thymoma than the world average.

See Myasthenia Gravis and Thymoma on the map

Where is the best place to study Myasthenia Gravis and Thymoma?

Among universities, judged by research, Harvard University, Yale University and Fudan University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 21.88%fractional works in this field (log) →share of work in the world top 10% →University of PalermoYale UniversityFudan UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 72.415.8%3.1×41 +12.3%
2Yale UniversityUnited States 63.623.5%3.6×16 +22.1%
3Fudan UniversityChina 62.919.6%4.1×27 +46.7%
4University of PalermoItaly 62.743.3%5.9×8 +262.7%
5University of TorontoCanada 61.221.1%2.6×21 +3.2%
6Sun Yat-sen UniversityChina 60.916.2%3.6×31 +60.3%
7University of OxfordUnited Kingdom 60.219.5%2.7×16 -3.8%
8Università Cattolica del Sacro CuoreItaly 56.616.6%8.6×15 +58.0%
9Leiden UniversityNetherlands 56.526.8%4.8×11 -9.4%
10George Washington UniversityUnited States 56.016.4%10.0×16 +56.8%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Myasthenia Gravis and Thymoma, country by country

Is Myasthenia Gravis and Thymoma research growing?

Output in 2022-2025 was 16% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Myasthenia Gravis and Thymoma.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Myasthenia Gravis and Thymoma as a percentage of every work published that year, 0.020% in 2024.

still counting0.020%0.040%0.060%Myasthenia Gravis and Thymoma0.022% in 202519801990200020102020

Fractional works of Myasthenia Gravis and Thymoma over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Myasthenia Gravis and Thymoma10.0% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Myasthenia Gravis and Thymoma. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.